Mithra Pharmaceuticals SA (MITRAB): key financial figures for fiscal year 2022 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022): €67.0M
Net Income/Loss (FY2022): -€59.6M
Total Assets (FY2022): €442.4M
Total Equity (FY2022): €33.7M
Cash Flows from Operating Activities (FY2022): -€56.8M

Source: Mithra Pharmaceuticals SA annual_report filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Mithra Pharmaceuticals SA (MITRAB): key financial figures for fiscal year 2022 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022): €67.0M
Net Income/Loss (FY2022): -€59.6M
Total Assets (FY2022): €442.4M
Total Equity (FY2022): €33.7M
Cash Flows from Operating Activities (FY2022): -€56.8M

Source: Mithra Pharmaceuticals SA annual_report filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.